Literature DB >> 1912446

Diagnostic utility of ultrasonography in hepatic venous outflow tract obstruction in a tropical country.

A Arora1, M P Sharma, S K Acharya, S K Panda, M Berry.   

Abstract

The present study was undertaken to define the role of ultrasonography (US) in screening and diagnosis of hepatic venous outflow tract obstruction. Forty-five consecutive patients clinically suspected to have hepatic venous outflow tract obstruction were included in the study for screening by US and for assessment of patency or block in the hepatic vein (HV) and/or inferior vena cava (IVC). Four patients were excluded from the study. Eleven patients had a diagnosis other than hepatic venous outflow tract obstruction and all these patients were found to have patent HV and IVC. Thirty patients were finally diagnosed to have hepatic venous outflow tract obstruction. Using US, as a screening test 27 (90%) out of 30 such cases were correctly identified as cases of hepatic venous outflow tract obstruction and in these cases the site of block in hepatic venous outflow tract (major HV and/or IVC) was correctly diagnosed in 90% of the cases. Our results indicate that US is a sensitive and accurate test and should be the initial investigation for screening and identifying the site of obstruction in patients with hepatic venous outflow tract obstruction.

Entities:  

Mesh:

Year:  1991        PMID: 1912446     DOI: 10.1111/j.1440-1746.1991.tb00873.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  2 in total

1.  Liver cirrhosis and hepatocellular carcinoma in hepatic vena cava disease, a liver disease caused by obstruction of inferior vena cava.

Authors:  Santosh Man Shrestha
Journal:  Hepatol Int       Date:  2009-01-23       Impact factor: 6.047

2.  Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment.

Authors:  Deepak N Amarapurkar; Sundeep J Punamiya; Nikhil D Patel
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.